文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

胃的癌前病变、胃癌和遗传性胃癌综合征。

Precancerous lesions of the stomach, gastric cancer and hereditary gastric cancer syndromes.

机构信息

Department of Pathology, Centro Hospitalar Universitário de São João (CHUSJ) & Department of Pathology, Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal and Instituto de Investigação e Inovação em Saúde (i3S) & Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), Portugal.

Anatomic Pathology Unit, Department of Surgical Sciences and Integrated Diagnostics (DICS), University of Genova, Italy.

出版信息

Pathologica. 2020 Sep;112(3):166-185. doi: 10.32074/1591-951X-166.


DOI:10.32074/1591-951X-166
PMID:33179620
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7931572/
Abstract

Gastric cancer accounts for about 6% of cancers worldwide, being the fifth most frequently diagnosed malignancy and the third leading cause of cancer related death. Gastric carcinogenesis is a multistep and multifactorial process and is the result of the complex interplay between genetic susceptibility and environmental factors. The identification of predisposing conditions and of precancerous lesions is the basis for screening programs and early stage treatment. Furthermore, although most gastric cancers are sporadic, familial clustering is observed in up to 10% of patients. Among them, hereditary cases, related to known cancer susceptibility syndromes and/or genetic causes are thought to account for 1-3% of all gastric cancers. The pathology report of gastric resections specimens therefore requires a standardized approach as well as in depth knowledge of prognostic and treatment associated factors.

摘要

胃癌占全球癌症的 6%左右,是第五种最常见的恶性肿瘤,也是癌症相关死亡的第三大主要原因。胃癌的发生是一个多步骤、多因素的过程,是遗传易感性和环境因素之间复杂相互作用的结果。易患疾病和癌前病变的确定是筛查计划和早期治疗的基础。此外,尽管大多数胃癌是散发性的,但在多达 10%的患者中观察到家族聚集现象。其中,与已知的癌症易感性综合征和/或遗传原因相关的遗传性病例被认为占所有胃癌的 1-3%。因此,胃切除标本的病理报告需要标准化的方法以及对预后和治疗相关因素的深入了解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b24/7931572/8b615d7ef4ab/pathol-2020-03-166-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b24/7931572/54e88e8d1d6b/pathol-2020-03-166-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b24/7931572/f1a88a075186/pathol-2020-03-166-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b24/7931572/23b3252f1c95/pathol-2020-03-166-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b24/7931572/71a283c6f47f/pathol-2020-03-166-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b24/7931572/f1be8a04026b/pathol-2020-03-166-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b24/7931572/b31e4d971c6e/pathol-2020-03-166-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b24/7931572/8b615d7ef4ab/pathol-2020-03-166-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b24/7931572/54e88e8d1d6b/pathol-2020-03-166-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b24/7931572/f1a88a075186/pathol-2020-03-166-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b24/7931572/23b3252f1c95/pathol-2020-03-166-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b24/7931572/71a283c6f47f/pathol-2020-03-166-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b24/7931572/f1be8a04026b/pathol-2020-03-166-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b24/7931572/b31e4d971c6e/pathol-2020-03-166-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b24/7931572/8b615d7ef4ab/pathol-2020-03-166-g007.jpg

相似文献

[1]
Precancerous lesions of the stomach, gastric cancer and hereditary gastric cancer syndromes.

Pathologica. 2020-9

[2]
Hereditary gastric cancer.

Best Pract Res Clin Gastroenterol. 2009

[3]
Recent advances in the pathology of heritable gastric cancer syndromes.

Histopathology. 2021-1

[4]
[Hereditary gastric cancer: Challenges for the pathologist in 2020].

Ann Pathol. 2020-4

[5]
Gastric tumours in hereditary cancer syndromes: clinical features, molecular biology and strategies for prevention.

Clin Transl Oncol. 2011-9

[6]
Hereditary Gastric Cancer Syndromes.

Surg Oncol Clin N Am. 2015-10

[7]
Hereditary gastric cancer.

Pathologe. 2012-11

[8]
Molecular pathology of familial gastric cancer, with an emphasis on hereditary diffuse gastric cancer.

J Clin Pathol. 2008-1

[9]
Familial Gastric Cancers.

Oncologist. 2015-12

[10]
Genetics, pathology, and clinics of familial gastric cancer.

Int J Surg Pathol. 2006-1

引用本文的文献

[1]
Global research trends on the association between gastric cancer and chronic atrophic gastritis: a bibliometric analysis.

Discov Oncol. 2025-8-24

[2]
The Prevalence of Infection in the Adult Population of Russia: A Systematic Review and Meta-Analysis.

Epidemiologia (Basel). 2025-8-12

[3]
Lipid metabolism-related genes in gastric cancer: Exploring oncogenic pathways.

World J Gastrointest Oncol. 2025-8-15

[4]
Clinical importance of E-cadherin deficiency in resectable gastric cancer: A nested case-control study.

Oncol Lett. 2025-7-4

[5]
Efficacy and validation of a clinical predictive model for chronic atrophic gastritis in patients: a multi-center retrospective analysis.

Front Med (Lausanne). 2025-6-19

[6]
Innovative Immunotherapy and Its Transformative Impact on Gastric Adenocarcinoma: A Comprehensive Review of the Disease's Origins, Epidemiology, Classification, Diagnosis, and Treatment Options.

ACS Pharmacol Transl Sci. 2025-4-18

[7]
Lactate metabolism-related genes serve as potential biomarkers for predicting gastric cancer progression and immunotherapy.

Discov Oncol. 2025-6-5

[8]
Huangqi fuling decoction inhibits the invasion and metastasis of gastric cancer via the TNF signaling pathway.

Sci Rep. 2025-6-4

[9]
Epidemiology of Helicobacter pylori, gastric precancerous lesions and gastric cancer: a multicenter, population-based cross-sectional study in Nanjing.

BMC Infect Dis. 2025-5-27

[10]
Current research status and hotspots of precancerous lesions of gastric cancer: a bibliometric analysis.

Front Oncol. 2025-4-29

本文引用的文献

[1]
Hereditary diffuse gastric cancer: updated clinical practice guidelines.

Lancet Oncol. 2020-8

[2]
Gastric cancer prevention strategies: A global perspective.

J Gastroenterol Hepatol. 2020-3-26

[3]
Redefinition of familial intestinal gastric cancer: clinical and genetic perspectives.

J Med Genet. 2021-1

[4]
Recent advances in diagnostic upper endoscopy.

World J Gastroenterol. 2020-1-28

[5]
Thirty years of Epstein-Barr virus-associated gastric carcinoma.

Virchows Arch. 2019-12-13

[6]
Pathological Tumor Regression Grade Classifications in Gastrointestinal Cancers: Role on Patients' Prognosis.

Int J Surg Pathol. 2019-12

[7]
Comparative genome-wide analysis of gastric adenocarcinomas with hyperplastic polyp components.

Virchows Arch. 2019-6-28

[8]
Comparison of CDH1 Penetrance Estimates in Clinically Ascertained Families vs Families Ascertained for Multiple Gastric Cancers.

JAMA Oncol. 2019-9-1

[9]
Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019.

Endoscopy. 2019-3-6

[10]
The incidence of neoplasia in patients with autoimmune metaplastic atrophic gastritis: a renewed call for surveillance.

Ann Gastroenterol. 2019

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索